论文部分内容阅读
目的:探讨香菇多糖联合化疗治疗卵巢癌的临床疗效。方法:选择2014.1-2016.6收治的卵巢癌患者88例,随机分为观察组和对照组,每组44例,对照组采用常规化疗方式进行治疗,观察组在对照组的基础上静脉滴注香菇多糖注射液。结果:(1)观察组完全缓解(CR)5例,部分缓解(PR)22例,总有效率为78.0%,对照组总有效率为48.7%(P<0.05);(2)观察组患者的病情控制时间、接受治疗总时间等指标与对照组相比,差异具有统计学意义(P<0.05)。结论:香菇多糖联合化疗治疗卵巢癌有效率高,好于单纯化疗,值得推广。
Objective: To investigate the clinical efficacy of lentinans in the treatment of ovarian cancer. Methods: A total of 88 patients with ovarian cancer who were admitted from 2014.1 to 2016.6 were randomly divided into observation group and control group, with 44 cases in each group. The control group was treated by conventional chemotherapy. The observation group received intravenous infusion of lentinan Injection. The total effective rate was 78.0% in the observation group and 48.7% in the control group (P <0.05). (2) In the observation group, 5 cases were completely relieved (CR), 22 cases were partially relieved (PR) Of the disease control time, the total time of treatment and other indicators compared with the control group, the difference was statistically significant (P <0.05). Conclusion: Lentinan combined with chemotherapy is effective in treating ovarian cancer, which is better than chemotherapy alone and is worth promoting.